上睑下垂
HMGB1
炎症体
半胱氨酸蛋白酶1
前列腺素E2
细胞迁移
下调和上调
程序性细胞死亡
炎症
白细胞介素
医学
自噬
细胞
细胞生物学
癌症研究
促炎细胞因子
前列腺素E
前列腺素
子宫内膜异位症
化学
免疫学
免疫组织化学
炎性细胞
生物
细胞凋亡
作者
Yi Huang,Ruiyun Li,Rui Hu,Jia Yao,Yuan Yang
标识
DOI:10.3390/ijms231911707
摘要
Endometriosis (EMS) is a common gynecological disease. Prostaglandin E2 (PGE2), which induces chronic pelvic inflammation and cell pyroptosis, a form of programmed cell death based on inflammasome activation, are involved in EMS, but the extent of their involvement and roles remain unclear. The present study aimed to evaluate PGE2-induced pyroptosis in EMS and the influence of PGE2 in EMS progression. Using western blotting, it was found that the expressions of PGE2 and pyroptosis-related proteins (NLRP3, cleaved caspase-1, interleukin (IL)-1β and IL-18) were higher in EMS tissues than in normal endometrial tissues. The levels of PGE2, IL-1β, and IL-18 in the serum of patients with EMS and cell culture fluids were also detected. Using the transwell assay, we verified that PGE2 promoted hEM15A migration via the NLRP3/caspase-1 pyroptotic pathway, and PGE2-induced pyroptosis upregulated the expressions of high mobility group box 1 (HMGB1), E-cadherin, and vimentin. Immunohistochemistry analysis confirmed that PGE2-induced pyroptosis contributed to EMS invasion. These results suggest that PGE2-induced pyroptosis affects the progression of EMS by changing the migration ability of pyroptotic cells and upregulating the expression of HMGB1, E-cadherin, and vimentin. Our findings provide crucial evidence for new treatment pathways and use of anti-inflammatory drugs in EMS.
科研通智能强力驱动
Strongly Powered by AbleSci AI